Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug

Francesco Passamonti, Mario Cazzola

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1284-1286
Number of pages3
Issue number11
Publication statusPublished - Nov 2004

ASJC Scopus subject areas

  • Hematology

Cite this